Mitch Maloy - Publications

Affiliations: 
2018-2020 Chemical and Biological Engineering State University of New York, Buffalo, Buffalo, NY, United States 

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Tamari R, Brown S, Devlin SM, Kosuri S, Maloy MA, Ponce DM, Sauter C, Shaffer B, Dahi P, Young JW, Jakubowski A, Papadopoulos EB, Castro-Malaspina H, Perales MA, Giralt SA, et al. Fractionated Infusion of Hematopoietic Progenitor Cells Does Not Improve Neutrophil Recovery or Survival in Allograft Recipients. Transplantation and Cellular Therapy. PMID 34214736 DOI: 10.1016/j.jtct.2021.06.022  0.391
2021 Brambilla CZ, Lobaugh SM, Ruiz JD, Dahi PB, Goldberg AD, Young JW, Gyurkocza B, Shaffer BC, Ponce DM, Tamari R, Escamilla MS, Flores NC, Politikos I, Scordo M, Shah GL, ... ... Maloy MA, et al. Relapse after allogeneic stem cell transplantation of acute myeloid leukemia and myelodysplastic syndrome and importance of second cellular therapy. Transplantation and Cellular Therapy. PMID 34033977 DOI: 10.1016/j.jtct.2021.05.011  0.36
2020 Ogoke O, Maloy M, Parashurama N. The science and engineering of stem cell-derived organoids-examples from hepatic, biliary, and pancreatic tissues. Biological Reviews of the Cambridge Philosophical Society. PMID 33002311 DOI: 10.1111/brv.12650  0.313
2020 Maloy MH, Ferrer MA, Parashurama N. In Vivo Differentiation of Stem Cell-derived Human Pancreatic Progenitors to Treat Type 1 Diabetes. Stem Cell Reviews and Reports. PMID 32844324 DOI: 10.1007/S12015-020-10018-5  0.608
2020 Cerrano M, Ruella M, Perales MA, Vitale C, Faraci DG, Giaccone L, Coscia M, Maloy M, Sanchez-Escamilla M, Elsabah H, Fadul A, Maffini E, Pittari G, Bruno B. The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice. Frontiers in Immunology. 11: 888. PMID 32477359 DOI: 10.3389/fimmu.2020.00888  0.343
2020 Lin RJ, Ho C, Devlin SM, Ruiz JD, Maloy MA, Shah GL, Perales MA, Dahi PB, Giralt SA, Scordo M, Schöder H, Hamlin PA, Sigler AM, Dogan A, Sauter CS. Impact of allogeneic hematopoietic cell transplantation on immune evasive mechanisms in relapsed refractory large B-cell lymphoma. Bone Marrow Transplantation. PMID 32404978 DOI: 10.1038/S41409-020-0942-1  0.302
2019 Lin A, Maloy M, Su Y, Bhatt V, DeRespiris L, Griffin M, Lau C, Proli A, Barker J, Shaffer B, Giralt SA, Jakubowski AA, Papadopoulos EB, Papanicolaou GA, Seo SK, et al. Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: real world experience. Transplant Infectious Disease : An Official Journal of the Transplantation Society. e13187. PMID 31585500 DOI: 10.1111/tid.13187  0.317
2019 Bryant AR, Hilden P, Giralt S, Chung DJ, Maloy M, Landau H, Landgren O, Scordo M, Shah G, Smith EL, O'Reilly RJ, Perales MA, Koehne G. Pre-salvage ISS and Other Important Outcome Associations in CD34 Selected Allogeneic Hematopoietic Stem Cell Transplant for Multiple Myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31493537 DOI: 10.1016/J.Bbmt.2019.08.023  0.324
2019 Jain T, Sauter CS, Shah GL, Maloy MA, Chan J, Scordo M, Avecilla ST, Batlevi Y, Dahi PB, Batlevi CW, Lia Palomba M, Giralt SA, Perales MA. Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma. Leukemia. PMID 31114023 DOI: 10.1038/s41375-019-0476-y  0.325
2018 Malard F, Labopin M, Cho C, Blaise D, Papadopoulos EB, Passweg J, O'Reilly R, Forcade E, Maloy M, Volin L, Castro-Malaspina H, Hicheri Y, Jakubowski AA, Orvain C, Giralt S, et al. Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC. Journal of Hematology & Oncology. 11: 127. PMID 30342553 DOI: 10.1186/S13045-018-0668-3  0.405
2018 Rosillo C, Avila AM, Huang YT, Devlin S, Cho C, Montoro J, Maloy MA, Papanicolaou GA, Barba P, Perales MA. Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Transplant Infectious Disease : An Official Journal of the Transplantation Society. e12897. PMID 29668073 DOI: 10.1111/Tid.12897  0.346
2018 Kim SJ, Huang YT, Foldi J, Lee YJ, Maloy M, Giralt SA, Jakubowski AA, Papanicolaou GA. Cytomegalovirus (CMV) resistance in CD34selected hematopoietic cell transplant (HCT) recipients. Transplant Infectious Disease : An Official Journal of the Transplantation Society. e12881. PMID 29570237 DOI: 10.1111/Tid.12881  0.33
2018 Lin RJ, Shahrokni A, Dahi PB, Jakubowski AA, Devlin SM, Maloy MA, Robinson KS, Perales MA, Shah GL, Korc-Grodzicki B, Giralt SA. Pretransplant comprehensive geriatric assessment in hematopoietic cell transplantation: a single center experience. Bone Marrow Transplantation. PMID 29523890 DOI: 10.1038/S41409-018-0151-3  0.301
2018 Tamari R, Oran B, Hilden P, Maloy M, Kongtim P, Papadopoulos EB, Rondon G, Jakubowski AA, Andersson BS, Devlin SM, Ahmed S, Popat UR, Ponce D, Chen J, Sauter C, et al. Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected or Unmodified Hematopoietic Stem Cells Transplants. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29325829 DOI: 10.1016/J.Bbmt.2018.01.001  0.324
2017 Jakubowski AA, Petrlik E, Maloy M, Hilden P, Papadopoulos E, Young JW, Boulad F, Castro-Malaspina H, Tamari R, Dahi PB, Goldberg J, Koehne G, Perales MA, Sauter CS, O'Reilly RJ, et al. T-Cell Depletion as an Alternative Approach for Patients >55 Years Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28734876 DOI: 10.1016/J.Bbmt.2017.06.024  0.407
2015 Fischer A, Jakubowski AA, Lacouture ME, Hollmann TJ, Drucker AM, Maloy M, Prockop S, Querfeld C, Busam KJ, Pulitzer MP. Histopathologic Features of Cutaneous Acute Graft-Versus-Host Disease in T-Cell-Depleted Peripheral Blood Stem Cell Transplant Recipients. The American Journal of Dermatopathology. 37: 523-9. PMID 26091510 DOI: 10.1097/DAD.0000000000000357  0.336
Show low-probability matches.